Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Riluzole increases glutamate uptake by cultured C6 astroglial cells.
Compositional Changes of B and T Cell Subtypes during Fingolimod Treatment in Multiple Sclerosis Patients: A 12-Month Follow-Up Study.
Sex as a determinant of relapse incidence and progressive course of multiple sclerosis.
FDA approves clinical trial of TDI-132 (Gilenya) in ALS patients
Corticosteroids provoke acute endothelial injury - an ideal ground for thrombosis in multiple sclerosis.
Differences in Diffusion Tensor Imaging-Derived Metrics in the Corpus Callosum of Patients With Multiple Sclerosis Without and With Gadolinium-Enhancing Cerebral Lesions.
Neurorehabilitation for other neurologic disorders.
Substance Name: Riluzole
Social cognition in pediatric-onset multiple sclerosis (MS).
Inflammatory events at blood-brain barrier in neuroinflammatory and neurodegenerative disorders: implications for clinical disease.
FDA approves first oral drug to reduce MS relapses
Early intervention with gene-modified mesenchymal stem cells overexpressing interleukin-4 enhances anti-inflammatory responses and functional recovery in experimental autoimmune demyelination.
Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions.
Targeting IRF4 in autoimmune diseases.
Periventricular Demyelination and Axonal Pathology Is Associated with Subependymal Virus Spread in a Murine Model for Multiple Sclerosis.
Impact of Depression, Fatigue and Disability on Quality of Life in Chinese Patients with Multiple Sclerosis.
One of the oldest patients with Neuromyelitis Optica in the literature.
In Vivo Brain MR Imaging at Subnanoliter Resolution: Contrast and Histology.
The influence of tetracyclines on T cell activation.
Pharmacology of HIV integrase inhibitors.
Genetic and epigenetic fine mapping of causal autoimmune disease variants.
The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy.
Disease exacerbation of multiple sclerosis is characterized by loss of terminally differentiated autoregulatory CD8+ T cells.
Implication of perturbed axoglial apparatus in early pediatric multiple sclerosis.
CD44 is required for the migration of transplanted oligodendrocyte progenitor cells to focal inflammatory demyelinating lesions in the spinal cord.
Pages
« first
‹ previous
…
201
202
203
204
205
206
207
208
209
…
next ›
last »